Premium
Oral Contraceptives and Thrombo‐embolism
Author(s) -
McQueen E. G.
Publication year - 1972
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.1972.tb02331.x
Subject(s) - medicine , embolism , thrombosis , pathological , family planning , research methodology , population , intensive care medicine , physiology , environmental health
SUMMARY Oestrogencontaining oral contraceptives increase many of the factors involved in thrombosis, presumably as a result of hepatic enzyme‐induction, Clinical and pathological data suggest a special liability to thrombotic complications and retrospective statistical surveys appear to have confirmed an increased mortality and morbidity. It is possible that the diminished oestrogen content of oral contraceptives now in use may be diminishing the risk.